Status:
COMPLETED
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
Lead Sponsor:
Ajou University School of Medicine
Conditions:
Chronic Urticaria
Eligibility:
All Genders
12+ years
Brief Summary
A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria
Detailed Description
* For four weeks * After the researcher confirms the selection / exclusion criteria on the baseline, the UAS, K-UCT, and CU-QoL are created and randomized from the subject. * Receive UAS, K-UCT, and C...
Eligibility Criteria
Inclusion
- Adolescents and adults over 12 years
- Clinical diagnosis of chronic urticaria due to wheal reaction, itching, angioedema over 6 weeks
- Antihistamine 2 or 2 kinds of treatment for more than 2 weeks even if the symptoms are not controlled
- Those who do not have other chronic skin diseases
Exclusion
- None
Key Trial Info
Start Date :
August 24 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 24 2019
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03293225
Start Date
August 24 2017
End Date
May 24 2019
Last Update
July 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Medical Hospital
Suwon, South Korea